Good morning. It's July 8.

This week is about your brain. All of it.

Scientists just named a completely new way brain cells die in Alzheimer's. They also found out why some brains fight back. And Big Pharma just dropped $140M on a way to regenerate your immune system's most underrated organ.

Let's get into it.

The rundown for this week:

Let's get to it. 👇

AlzeCure signs a $2.2B deal with QuantumCell to advance its Alzheimer's platform - rather than clearing amyloid after it forms, AlzeCure targets neuronal survival and plasticity directly. A $2.2B partnership signals real capital moving toward a non-amyloid Alzheimer's approach. Longevity.Technology

Drinking to cope with stress when you're young may permanently rewire the brain - new research shows early-life stress drinking can cause lasting changes to brain chemistry, reducing its ability to adapt to challenges later in life. ScienceDaily

Evipedia is expanding its evidence-based review platform to cover peptides - bringing the same rigor to a category that has long run on anecdote and gym-floor folklore rather than independent systematic review. Longevity.Technology

Osteopenia is silently weakening bones in millions of people - and most don't know they have it - the warning stage before osteoporosis, it develops without symptoms and is usually only caught after a fracture. A DEXA scan is the only way to know where you stand. ScienceDaily

Men's skin ages fast once collagen drops. Most guys notice too late — when the eye bags, dark spots, and wrinkles have already set in. Particle Face Cream is a 6-in-1 fix. Two minutes a day. Trusted by over a million men. 30-day guarantee. 20% off, code BH20.

Try It Risk-Free

For decades, scientists knew something was wrong with how we understood Alzheimer's.

Toxic proteins accumulate in neurons. Neurons die. Dementia follows. That much was established. What was missing: the mechanism. How, exactly, do those toxic proteins kill brain cells?

Researchers at King's College London and the UK Dementia Research Institute just published an answer in Nature Communications. They discovered a previously unknown form of cell death - a process they've named karyoptosis - that may be the missing link between toxic protein buildup and neuron death in Alzheimer's disease and frontotemporal dementia (FTD).

FTD is a type of dementia that primarily affects personality, behavior, and language rather than memory - caused by protein accumulation in the brain's frontal and temporal lobes.

The science breakdown:

Why does naming a new death pathway matter? Because you can't target what you can't see. Existing Alzheimer's drugs have largely focused on clearing amyloid and tau proteins after they build up. Karyoptosis gives researchers a specific downstream process to interrupt before cells are destroyed - a new class of treatment target that didn't exist last week.

Still early. Still preclinical in terms of treatment. But this is the kind of mechanistic clarity the field has needed for a long time.

👉 ScienceDaily | Alzheimer's Research UK | Nature Communications

Maybe you've spent months reading about longevity science and don't know where to start. Maybe you're already tracking biomarkers and have hit a ceiling.

Either way, you've got the same problem: you're doing this alone.

Peak Protocol is four days in the Colorado mountains where you get tested, you meet the researchers, and you leave with a written protocol built around your body.

Use code STAYINALIVE for $300 OFF the deposit.

United Therapeutics just acquired Thymmune Therapeutics for $140 million. United Therapeutics is a publicly traded pharma company best known for its rare disease treatments. Thymmune is working on something far less well-known: rebuilding the thymus.

You've seen us write about the thymus before. It's the organ that trains your immune system's T cells - the specialized hunters that go after infected tissue and cancer cells. The problem: the thymus shrinks dramatically with age, a process called thymic involution, where active immune tissue is gradually replaced by fat. By middle age, most people are producing a fraction of the new T cells they made in their 20s.

Fewer new T cells means a slower, less adaptable immune system. And a slower immune system means faster aging across essentially every organ system that depends on immune surveillance to stay healthy - which is most of them.

Thymmune is developing technology to regenerate the thymus - engineering the conditions for new thymic tissue to form and function. The science is early. But United Therapeutics paid nine figures to own it, which tells you what they think it's worth.

The business signal here is the important thing. This isn't a longevity-focused seed fund making a speculative bet. This is a revenue-generating pharmaceutical company with regulatory infrastructure deciding that thymic rejuvenation belongs in its pipeline. That's a different kind of validation - and it's the kind that changes how the rest of the industry looks at a nascent category.

👉 Longevity.Technology

Concierge health clinics that test this deeply charge $15,000 a year. Superpower charges $199.

For that you get a single blood draw covering 100+ biomarkers - hormones, thyroid, metabolic function, inflammation, cardiovascular markers, nutrients, liver, kidney, and immune health - plus a personalized action plan, and 24/7 access to a care team, and a supplement marketplace with members-only pricing.

Testing happens at 2,000+ labs across the US, or you can book a home visit. HSA and FSA eligible.

Results land in your dashboard within about a week, organized into 17 health scores, a biological age estimate, and a clear breakdown of what to do next. You can sync your wearables, upload old lab PDFs, and track your trends over time.

If you've been optimizing sleep, training, and nutrition but have never actually looked under the hood - this is the missing piece.

👉 Get Superpower - use code STAYIN20OFF for $20 off your first purchase

Here's the counterpoint to this week's From the Clinic.

We've spent decades mapping how Alzheimer's destroys the brain. This week, scientists turned the lens around: why do some brains fight back?

A new study published in ScienceDaily on July 3 found that some brains appear to actively resist Alzheimer's by helping immature brain cells - neural stem cells in the process of becoming fully functional neurons - survive the kind of toxic protein damage that normally kills them.

The implication: adult neurogenesis - the brain's ability to generate new neurons throughout life, a process once thought to stop in early childhood before being confirmed in adults - may play a protective role that goes beyond simply replenishing lost cells. These immature neurons appear to be more resistant to the toxic protein aggregation that drives Alzheimer's pathology.

In practical terms, what keeps adult neurogenesis going? The research points to the usual suspects that show up across every corner of the longevity field: regular aerobic exercise, quality sleep, stress reduction, and a nutrient-rich diet. What's new is the specific mechanism connecting these lifestyle factors to Alzheimer's resilience.

This is early research, and the exact pathway is still being mapped. But the directional signal is encouraging: the brain has its own defense systems, and the tools to strengthen them are already available.

Paired with this week's karyoptosis discovery, the picture is becoming clearer. We now know one key way the brain loses - and a mechanism by which some brains push back.

👉 ScienceDaily

Your body runs on a precise 24-hour biological clock that governs virtually everything - metabolism, immune function, hormone release, DNA repair. Disrupt it long enough and you age faster. That part is settled science.

Panda is one of the world's leading circadian rhythm researchers at the Salk Institute. He's spent decades running human trials on time-restricted eating - the practice of aligning your meals with your body's internal clock rather than eating whenever.

This is where the science in this space actually comes from. The book translates it directly: the optimal eating window, why light exposure matters as much as food timing, and how most modern schedules are quietly working against your biology. For readers who already know what to eat, this is the book on when to eat it.

Your weekly dose of scientific health advances with AI 👇

Confirmed sponsorships are filling up ad slots fast. To promote your longevity / biohacking product to our niche audience, download the media kit and get in touch with Sebastian at [email protected]